Clinical Trial Update: Study of Pomalidomide, Dexamethasone, and Romidepsin for Rel/Ref Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating pomalidomide, dexamethasone, and romidepsin for relapsed/refractory multiple myeloma was terminated. Results were posted January 31…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)
• Romidepsin (romidepsin)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-01-31